Guardian Capital (Canada)’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Guardian Capital (Canada)'s BIIB Position: Q2 2018 in Review
Guardian Capital (Canada) sold out of Biogen (BIIB) in Q2 2018, closing a stake of 1,343 shares — an estimated $367K sold.
Guardian Capital (Canada) first reported a position in BIIB in Q4 2013 and held it in 15 quarters. The position peaked at $1.39M in Q3 2014. 1,098 funds tracked by Wall St. Rank hold BIIB as of Q2 2018.
- Guardian Capital (Canada) reported no remaining Biogen position as of Q2 2018 after selling out during the quarter.
- Guardian Capital (Canada) sold 1,343 Biogen shares in Q2 2018, an estimated $367K.
- Guardian Capital (Canada) first reported a position in Biogen in Q4 2013 and held it in 15 quarters.
- Guardian Capital (Canada)'s Biogen position peaked at $1.39M in Q3 2014.
- 1,098 funds tracked by Wall St. Rank held Biogen as of Q2 2018.
Based on Guardian Capital (Canada)'s 13F filing for Q2 2018, filed 14 Aug 2018.